Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014, Article ID 427613, 5 pages
http://dx.doi.org/10.1155/2014/427613
Case Report

Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Service de Radiothérapie Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, France

Received 22 November 2013; Accepted 19 December 2013; Published 20 February 2014

Academic Editors: K. Kawauchi and P. Tsirigotis

Copyright © 2014 Marguerite Tyran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Nogová, “Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group,” Journal of Clinical Oncology, vol. 26, no. 3, pp. 434–439, 2008. View at Google Scholar
  2. C. Jackson, B. Sirohi, D. Cunningham, A. Horwich, K. Thomas, and A. Wotherspoon, “Lymphocyte-predominant Hodgkin lymphoma-clinical features and treatment outcomes from a 30-year experience,” Annals of Oncology, vol. 21, no. 10, pp. 2061–2068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. I. A. Lee and A. S. LaCasce, “Nodular lymphocyte predominant Hodgkin lymphoma,” Oncologist, vol. 14, no. 7, pp. 739–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. C. Chen, M. S. Chin, A. K. Ng et al., “Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up,” Journal of Clinical Oncology, vol. 28, no. 1, pp. 136–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Orlandi, M. Lazzarino, E. Brusamolino et al., “Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence,” Leukemia and Lymphoma, vol. 26, no. 3-4, pp. 359–368, 1997. View at Google Scholar · View at Scopus
  6. L. Nogová, T. Reineke, H. T. Eich et al., “Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG),” Annals of Oncology, vol. 16, no. 10, pp. 1683–1687, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Wilder, P. J. Schlembach, D. Jones et al., “European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease,” Cancer, vol. 94, no. 6, pp. 1731–1738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. H. Swerdlow, WHO Classification of Tumours of Haematopoeitic and Lymphoid Tissues, IARC, Lyon, France, 4th edition, 2008.
  9. A. Wirth, K. Yuen, M. Barton et al., “Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group,” Cancer, vol. 104, no. 6, pp. 1221–1229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Diehl, M. Sextro, J. Franklin et al., “Clinical presentation, course, and prognostic factors in lymphocyte- predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on lymphoma project on lymphocyte-predominant Hodgkin's disease,” Journal of Clinical Oncology, vol. 17, no. 3, pp. 776–783, 1999. View at Google Scholar · View at Scopus
  11. S. Bodis, M. D. Kraus, G. Pinkus et al., “Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease,” Journal of Clinical Oncology, vol. 15, no. 9, pp. 3060–3066, 1997. View at Google Scholar · View at Scopus
  12. R. M. Meyer, M. K. Gospodarowicz, J. M. Connors et al., “ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma,” The New England Journal of Medicine, vol. 366, no. 5, pp. 399–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. C. Hodgson, “Late effects in the era of modern therapy for Hodgkin lymphoma,” American Society of Hematology Education Program, vol. 2011, pp. 323–329, 2011. View at Google Scholar · View at Scopus
  14. E. S. Koh, T. H. Tran, M. Heydarian et al., “A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk,” Radiation Oncology, vol. 2, no. 1, article 13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. J. Schlembach, R. B. Wilder, D. Jones et al., “Radiotherapy alone for lymphocyte-predominant Hodgkin's disease,” Cancer Journal, vol. 8, no. 5, pp. 377–383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Girinsky, R. van der Maazen, L. Specht et al., “Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines,” Radiotherapy and Oncology, vol. 79, no. 3, pp. 270–277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Al-Mansour, J. M. Connors, R. D. Gascoyne, B. Skinnider, and K. J. Savage, “Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma,” Journal of Clinical Oncology, vol. 28, no. 5, pp. 793–799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Biasoli, A. Stamatoullas, V. Meignin et al., “Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the adult lymphoma study group,” Cancer, vol. 116, no. 3, pp. 631–639, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Anagnostopoulos, M. L. Hansmann, K. Franssila et al., “European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes,” Blood, vol. 96, no. 5, pp. 1889–1899, 2000. View at Google Scholar · View at Scopus
  20. R. J. Lukes and J. J. Butler, “The pathology and nomenclature of Hodgkin's disease,” Cancer Research, vol. 26, no. 6, pp. 1063–1083, 1966. View at Google Scholar · View at Scopus